| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 29, 2021 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,200 | $3.98 | 2,200 |
| Nov 29, 2021 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 150 | $3.98 | 5,025 |
| Aug 15, 2022 |
Director
Trans History: 11
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 20,000 | $3.62 | -- |
| May 16, 2022 |
Director
Trans History: 18
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 10,000 | $1.60 | 13,894 |
| May 12, 2022 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 50,141 | $1.41 | 538,556 |
| May 12, 2022 |
Chief Operating Officer
Trans History: 19
|
Chief Operating Officer | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 41,496 | $1.41 | 216,669 |
| Jan 18, 2019 |
Chief Operating Officer
Trans History: 19
|
Chief Operating Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | $1.30 | 6,815 |
| Feb 15, 2024 |
CHIEF MEDICAL OFFICER
Trans History: 12
|
CHIEF MEDICAL OFFICER | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,081 | $1.27 | 31,487 |
| Feb 15, 2024 |
GENERAL COUNSEL
Trans History: 4
|
GENERAL COUNSEL | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 402 | $1.27 | 3,525 |
| Feb 15, 2024 |
Director, PRESIDENT AND CEO
Trans History: 29
|
Director, PRESIDENT AND CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 3,073 | $1.27 | 77,663 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.